Alternative splicing of TGF-betas and their high-affinity receptors TβRI, TβRII and TβRIII (betaglycan) reveal new variants in human prostatic cells
2007

New Variants of TGF-beta Receptors in Prostate Cells

publication Evidence: moderate

Author Information

Author(s): Konrad Lutz, Jonas Scheiber, Elke Völck-Badouin, Marcel M. Keilani, Leslie Laible, Heidrun Brandt, Ansgar Schmidt, Gerhard Aumüller, Rainer Hofmann

Primary Institution: Department of Urology, Medical Faculty, Marburg, Germany

Hypothesis

The study investigates the expression and alternative splicing of TGF-beta ligands and their receptors in human prostatic cells.

Conclusion

The study identifies novel splice variants of TGF-beta receptors in human prostate cells, contributing to the complexity of the TGF-beta signaling pathway.

Supporting Evidence

  • A novel human receptor transcript TβRIIC was identified in prostatic cancer cells.
  • The receptor variant TβRIB was found to have additional amino acids.
  • Expression of TGF-β ligands and receptors was heterogeneous in prostate cells.
  • Stimulation of PC-3 cells with TGF-β2 significantly increased PAI-1 secretion.

Takeaway

Scientists found new versions of proteins that help control cell growth in the prostate, which could be important for understanding prostate cancer.

Methodology

The study analyzed mRNA expression and localization of TGF-beta ligands and receptors in human prostatic cells using RT-PCR and immunohistochemistry.

Limitations

The expression of some splice variants was weak and may not represent their full biological significance.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2164-8-318

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication